Lupin Limited has launched the Olmesartan Medoxomil tablets, 5 mg, 20 mg, and 40 mg, after receiving an approval from the US FDA. These tablets are the AB-rated generic equivalent of Daiichi Sankyo's Benicar tablets, indicated for the treatment of hypertension, alone or in combination with other antihypertensive agents, to lower blood pressure.

Why is The Government So Bad at Health Care?



Digital version